Article info
Letter
Retreatments must be included in the evaluation of device performance
- Correspondence to Dr René Chapot, Department of Interventional and Diagnostic Neuroradiology, Alfried Krupp Hospital, Essen 45131, Germany; Rchapot{at}icloud.com
Citation
Retreatments must be included in the evaluation of device performance
Publication history
- Received July 12, 2020
- Accepted August 19, 2020
- First published September 14, 2020.
Online issue publication
March 15, 2021
Article Versions
- Previous version (14 September 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.